FierceBiotech

Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding within Google parent company Alphabet, raising $600 million to advance its ...
SiliconANGLE

Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine

Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
GEN

DeepMind Spinout Isomorphic Labs Raises $600M Toward AI Drug Design

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...
Wall Street Journal

Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development

Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.
FierceBiotech

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM

Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value. The two separate pacts ...